Skip to content

DOKTER TOM MOERMAN

Active
Private limited companyfounded 2020active for 6 yearsBuffelstraat 12, 9000 Gent, BelgiumKBO/BCE: BE 0753.841.339
Summary

DOKTER TOM MOERMAN has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €110,061 and a net result of €470,061. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 12% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

DOKTER TOM MOERMAN was incorporated on 9 September 2020 as a private limited company.1 Total assets rose from €130,100 in 2021 to €1.4m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
09-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
14-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
27-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 27 days late
2023
31-12
Financial Equity above €1mequity €1.2m ▲71.9%
A profit in every financial year since 2021 builds equity to €1.2m.
13-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Highest result from 2021 to 2025net €608,601 ▲593%
Operating result €809,812, net result €608,601, both a record.
31-12
Financial Equity above €500,000equity €700,188 ▲655%
A profit in every financial year since 2021 builds equity to €700,188.
14-07
NBB filing Annual accounts filed
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.